Renewal of licensing fee for the transgenic mouse strain, B-hIL2RA
75N98026Q00467 · HEALTH AND HUMAN SERVICES, DEPARTMENT OF
A NAICS 51321 solicitation, performed in MD, with responses due 2026-06-08. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
The MIB is conducting pre-clinical research on photoimmunotherapy (PIT), a targeted treatment approach that uses light activation to destroy specific cells. One area of this research focuses on IL2RA, a protein expressed on regulatory T cells (Tregs). These cells can reduce the immune systems abilit
Comparable recent awards in NAICS 51321
| Winner | Award value | Offers | Date |
|---|---|---|---|
| Detail available to signed-in users. | |||
Questions
What is solicitation 75N98026Q00467?
Renewal of licensing fee for the transgenic mouse strain, B-hIL2RA, issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF, under NAICS 51321 (NAICS 51321), performed in MD. Responses are due 2026-06-08.
Is 75N98026Q00467 set aside?
NONE. Check the notice on SAM.gov for the eligibility language that governs.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.